-
<![CDATA[FDA Grants Fast Track Designation to UB-VV111 for R/R B-Cell Malignancies ]]>
30 Sep 2025 17:27 GMT
… Luke Walker, MD, chief medical officer of Umoja Biopharma, … in 2024, the FDA cleared the investigational new drug (IND) application … in another interventional clinical trial.
Patients will receive a … or followed by rapamycin (Rapamune) treatment.3,4 UB-VV111 …
-
Scientists Found a Miracle Drug in Easter Island’s Soil. The Natives Never Saw a Dime.
30 Sep 2025 14:25 GMT
… cancer treatments and organ transplantations.
Although rapamycin eventually became a billion-dollar drug … scientific colonialism.
When Medical Expedition to Easter … Rapamune. Despite the name’s homage to the drug … another life-changing remedy. Hopefully when …
-
A billion-dollar drug was found in Easter Island soil – what scientists and companies owe the Indigenous people they studied
29 Sep 2025 13:22 GMT
… pharmaceutical success story. Yet the history told about this “miracle drug … treat various types of cancer, and researchers are … most talked-about drugs in medicine.
Chemical structure of … 1990s as the immunosuppressant Rapamune. While Sehgal’s persistence …
-
Rocket to relaunch rare disease trial after FDA approval
21 Aug 2025 16:25 GMT
… Food and Drug Administration (FDA) has given Rocket Pharmaceuticals approval to … the treatment regimen, which Rocket incorporated into the trial … alleging that the biotech hid key safety issues … This includes the use of Rapamune (sirolimus), rituximab and …
-
Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
18 Aug 2025 12:30 GMT
… for Medicine. For more information about the Serenta trial, … transplantation as Rapamune®(Pfizer). Through the … contact: About Biodexa Pharmaceuticals PLC Biodexa Pharmaceuticals PLC (listed on … Bladder Cancer; tolimidone, under development for the treatment of …
-
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
14 Jul 2025 12:30 GMT
… Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC … to colorectal cancer. The only current treatment option is … Designation by the FDA, Orphan Drug designation in Europe … in renal transplantation as Rapamune®. Through the use …
-
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
25 Jun 2025 12:30 GMT
… Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC … in renal transplantation as Rapamune®(Pfizer). Through the … Bladder Cancer; tolimidone, under development for the treatment of … and is activated during tumorigenesis. Tolimidone is an …
-
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis
28 Jun 2025 09:38 GMT
Biodexa Pharmaceuticals, a clinical stage … products for the treatment of diseases with unmet medical needs, announced … adenomatous polyposis typically leads to cancer of the colon and… rejection in renal transplantation as Rapamune (Pfizer). Through the use …
-
First drug OK'd for most common heart condition in cats
25 Apr 2025 00:38 GMT
… in Australia prescribed him Rapamune, a formulation of … Felycin contains rapamycin, a medication with a variety of applications … the drug, which also is being investigated as a cancer treatment. … Miller followed the Felycin trial study with interest. Once …
-
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
10 Mar 2025 12:30 GMT
… -controlled trial in 168 patients, randomized 2:1 drug … renal transplantation as Rapamune®(Pfizer). Through the … #47;. About Biodexa Pharmaceuticals PLC Biodexa Pharmaceuticals PLC (listed on … Blader Cancer; tolimidone, under development for the treatment of …